Articles from PursueCare

PursueCare, a virtual clinic for substance use disorder (SUD) treatment, will participate in a panel exploring partnerships and strategies for integrated, whole-person care models in behavioral health at the 2025 Behavioral Health Business (BHB) Addiction Treatment Forum in Chicago, Ill., on July 17, 2025, at Convene (311 W Monroe). The forum also spotlights current investment and operational trends shaping the addiction treatment industry.

PursueCare, a leading provider of virtual addiction treatment and specialized pharmacy services, is proud to announce its participation in the 56th Annual American Society of Addiction Medicine (ASAM) Conference in Denver, Colo., April 24-27, 2025. The event gathers top experts, clinicians, and innovators in addiction medicine to advance science, practice, and policy in the field.

PursueCare, a leading provider of virtual addiction treatment and specialized pharmacy services, is proud to announce its participation in the Rx and Illicit Drug Summit, taking place April 21–24, 2025, in Nashville, Tenn. Attendees can connect with the PursueCare team at Booth #422 to explore innovative digital health solutions for substance use disorder (SUD) and opioid use disorder (OUD).

PursueCare, a leading provider of virtual addiction treatment and specialized pharmacy services, announced today that its Chief Ambulatory Care Pharmacist, Dr. Elizabeth Basham, PharmD, has been honored with the prestigious Bowl of Hygeia award for an outstanding record of civic leadership. This award, presented by the West Virginia Pharmacists Association, recognizes Dr. Basham’s exceptional commitment to community service and advocacy in addiction care.

PursueCare, a leader in virtual addiction treatment, today announced the rollout of RESET® and RESET-O® , the only FDA-authorized prescription digital therapeutics (PDTs) for substance use disorder (SUD) and opioid use disorder (OUD). The groundbreaking app-based digital therapies deliver a self-guided 12-week course of cognitive behavioral therapy (CBT), in which patients are incentivized to complete lessons, adhere to treatment, and abstain from drug use. Demonstrated to reduce substance use, increase treatment retention, and reduce overall healthcare costs, the products are positioned to transform addiction treatment.

PursueCare, one of the leading national providers for virtual substance use disorder and mental health treatment, today announced the launch of virtual care services and outpatient clinic services in Pennsylvania and New Jersey.